Pre-procedural administration of aminophylline does not prevent AngioJet rheolytic thrombectomy-induced bradyarrhythmias

Journal of Invasive Cardiology

Volumn 17, Issue 1, 2005, Pages 19-22

  Lee, Michael S ^a   Makkar, Raj ^a   Singh, Varinder ^a   Rametta, Salvatore ^a   Valania, Gregory ^a   Platzman, Zlata ^a   Wilentz, James ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; ANJIOJET;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BRADYCARDIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; RHEOLYTIC THROMBECTOMY; SAPHENOUS VEIN GRAFT; THROMBUS; TREATMENT FAILURE;

ADULT; AGED; AMINOPHYLLINE; BRADYCARDIA; CARDIOTONIC AGENTS; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PHOSPHODIESTERASE INHIBITORS; PREOPERATIVE CARE; THROMBECTOMY; TREATMENT OUTCOME;

EID: 18244393541     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Ellis SG, Roubin GS, King SB, et al. Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty. Circulation 1988;77:372-379.
2. Mabin TA, Holmes DR, Smith HC, et al. Intracoronary thrombus: Role in coronary occlusion complicating percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985;5:198-202.
3. Saber RS, Edwards WD, Bailey KR, et al. Coronary embolization after balloon angioplasty or thrombolytic therapy: An autopsy study of 32 cases. J Am Coll Cardiol 1993;22:1283-1288.
4. Arora RR, Platko WP, Bhadwar K, Simpferdofer C. Role of intracoronary thrombus in acute complications during percutaneous transluminal coronary angioplasty. Cathet Cardiovasc Diagn 1989;16:226-229.
5. Lincoff AM, Popma JJ, Ellis SG, Hacker JA, Topol EJ. Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile. J Am Coll Cardiol 1992;19:926-935.
6. Verna E, Repetto S, Boscarini M, et al. Management of complicated coronary angioplasty by intracoronary urokinase and immediate re-angioplasty. Cathet Cardiovasc Diagn 1990;19:116-122.
7. Nakagawa Y, Matsuo S, Kimura T, et al. Thrombectomy with AngioJet catheter in native coronary arteries for patients with acute or recent myocardial infarction. Am J Cardiol 1999;83:994-999.
8. Silva JA, Ramee SR, Cohen DJ, et al. Rheolytic thrombectomy during percutaneous revascularization for acute myocardial infarction: Experience with the AngioJet catheter. Am Heart J 2001;141:353-359.
9. Ramee SR, Schatz RA, Carozza JP, et al. Results of the VEGAS-I pilot study of the Possis coronary AngioJet thrombectomy catheter. Circulation 1996;94:3622.
10. Kuntz RE, Baim DS, Cohen DJ, et al. A trial comparing rheolytic thrombectomy with intracoronary urokinase for coronary and vein graft thrombus (the Vein Graft AngioJet Study [VeGAS 2]). Am J Cardiol 2002;89:326-330.
11. Browne BM, Brenner AS, Ebersole D, et al. Prevention of rheolytic thrombectomy induced bradyarrhythmias with aminophylline. J Am Coll Cardiol 2003;41;18A.
12. Henry T, Murad B, Wahlberg MD, et al. Mechanism of heart block of the AngioJet catheter. Circulation 1997;96:1527.
13. Nakagawa Y, Matsuo S, Kimura T, et al. M. Thrombectomy with AngioJet catheter in native coronary arteries for patients with acute or recent myocardial infarction. Am J Cardiol 1999;83:994-999.
14. Belardinelli L, Linden J, Berne RM. The cardiac effects of adenosine. Prog Cardiovasc Dis 1989;32:73-97.
15. Belardinelli L, Shryock JC, Song Y, Wang D, Srinivas M. Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes. FASEB 1995;9:359-365.
16. King SB, Douglas JS. Normal coronary anatomy. In: Coronary Arteriography and Angioplasty. New York: McGraw-Hill, 1985.
17. Fontaine AB, Borsa JJ, Hoffer EK, et al. Type III heart block with peripheral use of the AngioJet thrombectomy system. J Vasc Interv Radiol 2001;12:1223-1225.
18. Whisenant BK, Baim DS, Kuntz RE, et al. JP. Rheolytic thrombectomy with the Possis AngioJet: technical considerations and initial clinical experience. J Invas Cardiol 1999;11:421-426.
19. Bertolet BD, McMurtrie EB, Hill JA, Belardinelli L. Theophylline for the treatment of atrioventricular block after myocardial infarction. Ann Intern Med 1995;123:509-511.
20. Patel AK, Skatrud JB, Thomsen JH. Cardiac arrhythmias due to oral aminophylline in patients with chronic obstructive pulmonary disease. Chest 1981;80:661-665.
21. Varriale P, Ramaprasad S. Aminophylline induced atrial fibrillation. Pacing Clin Eletrophysiol 1993;16:1953-1955.
22. Oei HH, Hale TH, Gandhi SS, Pilla TJ, Wegria R. Effect of aminophylline on coronary circulation and cardiac metabolism. Arch Int Pharmacodyn Ther 1977;229:95-104.
23. Rutherford JD, Vatner SF, Braunwald E. Effects and mechanism of action of aminophylline on cardiac function and regional blood flow distribution in conscious dogs. Circulation 1981;63:378-387.
24. Webb JG, Garere RG, Virmani R, et al. Retrieval and analysis of particulate debris after saphenous vein graft intervention. J Am Coll Cardiol 1999;34:468-475.
25. American College of Cardiology. 2004 Late Breaking Clinical Trials. New Orleans, LA. American College of Cardiology; 2004.
26. Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995;332:1553-1559.
27. Jordan RE, Mascelli MA, Nakada MT, Weisman HF. The pharmacology and clinical development of abciximab (c7E3 Fab, ReoPro): A monoclonal antibody inhibitor of GP IIb/IIIa and _v_3. In: Sasahara AA, Loscalzo J, eds. New Therapeutic Agents in Thrombosis and Thrombolysis. New York, NY: Marcel Dekker, Inc.,1997.
28. Kereiakes DJ, Broderick TM, Roth EM, et al. Time course, magnitude, and consistency of platelet inhibition by abciximab, tirofiban, or eptifibatide in patients with unstable angina pectoris undergoing percutaneous coronary intervention. Am J Cardiol 1999;84:391-395.